Aligos Therapeutics (ALGS) Revenue (2021 - 2025)
Historic Revenue for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $741000.0.
- Aligos Therapeutics' Revenue fell 4072.0% to $741000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 4768.65%. This contributed to the annual value of $3.6 million for FY2024, which is 6133.0% down from last year.
- Aligos Therapeutics' Revenue amounted to $741000.0 in Q3 2025, which was down 4072.0% from $965000.0 recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' Revenue registered a high of $4.3 million during Q2 2023, and its lowest value of $311000.0 during Q1 2025.
- In the last 5 years, Aligos Therapeutics' Revenue had a median value of $1.5 million in 2021 and averaged $1.8 million.
- As far as peak fluctuations go, Aligos Therapeutics' Revenue soared by 86376.02% in 2022, and later tumbled by 7529.11% in 2024.
- Over the past 5 years, Aligos Therapeutics' Revenue (Quarter) stood at $367000.0 in 2021, then skyrocketed by 863.76% to $3.5 million in 2022, then plummeted by 43.2% to $2.0 million in 2023, then crashed by 69.84% to $606000.0 in 2024, then increased by 22.28% to $741000.0 in 2025.
- Its Revenue stands at $741000.0 for Q3 2025, versus $965000.0 for Q2 2025 and $311000.0 for Q1 2025.